Pocket Naloxone
Bethesda, US · Founded 2019 · Delaware corporation · 2 known investors
Founders & leadership
AB
Andrea BarthwellNamed on SEC filing
BS
Behshad SheldonNamed on SEC filing
AM
Ashanthi MathaiNamed on SEC filing
SK
Serena KimNamed on SEC filing
KB
Kathryn BowsherNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$6.2M disclosed across 1 round · 2021
▶$6.2MraisedSep 2021 · 65 investors · PharmaceuticalsRule 506(b)
▶$6.2MraisedSep 2021 · 65 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrea BarthwellDirector
- Behshad SheldonDirector
- Ashanthi MathaiExecutive Officer, Director
- Serena KimExecutive Officer
- Kathryn BowsherDirector
- Offering amount
- $7.1M
- Amount sold
- $6.2M
- Minimum investment
- $10K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pocket Naloxone's investors?
- Pocket Naloxone's investors include Kern Venture Group, MedMountain Ventures.
- How much funding has Pocket Naloxone raised?
- Pocket Naloxone has disclosed $6.2M raised across 1 round.
- Where is Pocket Naloxone headquartered?
- Pocket Naloxone is headquartered in Bethesda, US.